Trial Profile
A randomised, double-blind, placebo-controlled study of Glypromate [glycine proline glutamate] in patients undergoing coronary artery bypass graft surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2007
Price :
$35
*
At a glance
- Drugs Glycine-proline-glutamate (Primary)
- Indications Mild cognitive impairment
- Focus Pharmacokinetics
- Acronyms SNUG
- Sponsors Neuren Pharmaceuticals
- 11 Sep 2007 New trial record.